CIPLA
|
The Current P/B Ratio of CIPLA is 3.94.
| Share Price | ₹1,516.7 | Dec 02,2025 |
| Market Cap | ₹122,515.0 Cr | |
| Book Value | ₹31,079.3 Cr | Mar2025 - Consolidated Results |
| Price/Book | 3.94x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of CIPLA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹122,515.0 Cr] as on Dec 02,2025
(/) Book Value [ ₹31,079.3 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 3.94x ]
Thus, for CIPLA , the investors are currently willing to pay '3.94 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CIPLA !
The chart below summarizes the trend in P/B Ratio of CIPLA over the last five years.
Historical PB (Price/Book ) ratio chart of CIPLA
PB Ratio Performance Analysis for CIPLA
- CIPLA 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.79x.
- CIPLA 's operated at median p/b ratio of 3.75x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/b ratio peaked in Mar2024 at 4.53x.
- CIPLA 's p/b ratio hit its five-year low in Mar2023 of 3.11x.
How does CIPLA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| CIPLA | 31,079.30 | 3.94 | 122,515.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.97 | 431,412.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.38 | 170,343.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 16.62 | 126,191.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.19 | 106,523.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.40 | 91,485.9 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.96 | 94,827.5 |
| LUPIN LTD | 17,119.50 | 5.56 | 95,164.1 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.16 | 70,654.5 |
| ABBOTT INDIA LTD | 4,204.27 | 14.78 | 62,121.2 |
| ALKEM LABORATORIES LTD | 11,948.70 | 5.64 | 67,442.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CIPLA 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.16x |
| Max industry PB | 16.62x |
| Median industry PB | 5.64x |
| Average industry PB | 7.24x |
You may also like the below Video Courses